局部洛萨坦用于已确定的角膜纤维化,具有基于机器学习的预测因素
Jorge Luis Domene-Hickman1, Luis Haro-Morlett1, Alejandro Lichtinger1
1Cornea, Instituto de Oftalmologia Fundacion Conde de Valenciana IAP, Mexico City, Mexico.
Therapeutic advances in ophthalmology
|November 17, 2025
概括
局部洛萨坦眼滴有效减少角膜纤维化和改善患者的视力. 这种治疗为增强角膜透明度和视觉功能提供了一个有希望的新选择.
科学领域:
- 眼科医生 眼科 眼科
- 再生医学是一种再生医学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 角膜纤维化严重损害视力,导致不透明和痕.
- 目前用于角膜纤维化治疗的疗法有效性有限.
- 肌纤维细胞的增殖是角膜纤维化病变的关键因素.
研究的目的:
- 评估局部洛萨坦1毫克/毫升在治疗角膜纤维化中的疗效.
- 评估局部洛萨坦对角膜透明度和视力敏度的影响.
- 使用机器学习模型识别视觉改进的预测因素.
主要方法:
- 一个前性的干预病例系列,涉及有角膜纤维化成年患者.
- 参与者接受局部洛萨坦1毫克/毫升每天六次,持续三个月.
- 评估结果使用视觉敏度,裂灯检查,角膜断层扫描和密度计.
主要成果:
- 平均未经纠正的距离视力敏度明显改善 (p=0.007).
- 角膜密度度下降,特别是在中端外围区域 (p=0.0184).
- 一个随机森林模型预测了视觉改善的准确率为84.21% (AUROC 0.76).
结论:
- 局部洛萨坦是角膜纤维化治疗的潜在治疗替代方案.
- 该药物改善角膜透明度和功能视力.
- 一个预测模型可以指导角膜纤维化治疗选择.
相关概念视频
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Open Angle Glaucoma: Treatment
940
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
940


